Investor List:

Top Medical Devices Series A Investors in Raleigh-Durham / Southeast US (24)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Medical Devices investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Krisztina 'Z' Holly, Investor at Good Growth Capital
Krisztina 'Z' Holly
Sweet spot: $500K
Range: $100K - $2.0M
Investors in United States, Investors in Los Angeles / Southern California, Investors in SF Bay Area (CA), Investors in Charleston (SC), Investors in Raleigh-Durham / Southeast US, Investors in Boston / New England, Investors in Boston (MA), Investors in Midwest, Investors in Arizona
Investors in Medical Devices (Pre-seed), Investors in Material Science (Pre-seed), Investors in Manufacturing (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in EnergyTech (Pre-seed), Investors in Manufacturing (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Material Science (Pre-seed), Investors in Material Science (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Manufacturing (Pre-seed), Investors in Material Science (Pre-seed), Investors in EnergyTech (Pre-seed), Investors in Space (Pre-seed), Investors in Space (Pre-seed), Investors in Space (Pre-seed), Investors in BioTech (Pre-seed), Investors in ClimateTech/CleanTech (Pre-seed), Investors in EnergyTech (Pre-seed), Investors in EnergyTech (Pre-seed), Investors in DeepTech (Pre-seed), Investors in DeepTech (Pre-seed), Investors in BioTech (Pre-seed), Investors in ClimateTech/CleanTech (Pre-seed), Investors in Space (Pre-seed), Investors in Manufacturing (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in ClimateTech/CleanTech (Pre-seed), Investors in BioTech (Pre-seed), Investors in Enterprise (Pre-seed), Investors in Material Science (Pre-seed), Investors in Enterprise (Pre-seed), Investors in ClimateTech/CleanTech (Pre-seed), Investors in Manufacturing (Pre-seed), Investors in AI (Pre-seed), Investors in AI (Pre-seed), Investors in Space (Pre-seed), Investors in DeepTech (Pre-seed), Investors in BioTech (Pre-seed), Investors in Material Science (Pre-seed), Investors in EnergyTech (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Enterprise (Pre-seed), Investors in AI (Pre-seed), Investors in Enterprise (Pre-seed), Investors in AI (Pre-seed), Investors in ClimateTech/CleanTech (Pre-seed), Investors in Space (Pre-seed), Investors in Manufacturing (Pre-seed), Investors in BioTech (Pre-seed), Investors in DeepTech (Pre-seed), Investors in EnergyTech (Pre-seed), Investors in BioTech (Pre-seed), Investors in ClimateTech/CleanTech (Pre-seed), Investors in AI (Pre-seed), Investors in Enterprise (Pre-seed), Investors in Enterprise (Pre-seed), Investors in AI (Pre-seed), Investors in Medical Devices (Seed), Investors in Manufacturing (Seed), Investors in Material Science (Seed), Investors in DeepTech (Seed), Investors in Material Science (Seed), Investors in Material Science (Seed), Investors in EnergyTech (Seed), Investors in DeepTech (Seed), Investors in EnergyTech (Seed), Investors in Space (Seed), Investors in Manufacturing (Seed), Investors in Medical Devices (Seed), Investors in Medical Devices (Seed), Investors in Space (Seed), Investors in Material Science (Seed), Investors in Space (Seed), Investors in Medical Devices (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in DeepTech (Seed), Investors in BioTech (Seed), Investors in Manufacturing (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in EnergyTech (Seed), Investors in Space (Seed), Investors in DeepTech (Seed), Investors in BioTech (Seed), Investors in Manufacturing (Seed), Investors in Material Science (Seed), Investors in EnergyTech (Seed), Investors in AI (Seed), Investors in Enterprise (Seed), Investors in BioTech (Seed), Investors in AI (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in Enterprise (Seed), Investors in Medical Devices (Seed), Investors in Manufacturing (Seed), Investors in Material Science (Seed), Investors in Space (Seed), Investors in DeepTech (Seed), Investors in AI (Seed), Investors in EnergyTech (Seed), Investors in AI (Seed), Investors in Enterprise (Seed), Investors in Medical Devices (Seed), Investors in BioTech (Seed), Investors in Enterprise (Seed), Investors in Manufacturing (Seed), Investors in Space (Seed), Investors in DeepTech (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in EnergyTech (Seed), Investors in BioTech (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in AI (Seed), Investors in BioTech (Seed), Investors in Enterprise (Seed), Investors in AI (Seed), Investors in Enterprise (Seed), Investors in Medical Devices (Series A), Investors in Manufacturing (Series A), Investors in Material Science (Series A), Investors in Material Science (Series A), Investors in Material Science (Series A), Investors in DeepTech (Series A), Investors in DeepTech (Series A), Investors in Medical Devices (Series A), Investors in Space (Series A), Investors in Medical Devices (Series A), Investors in Material Science (Series A), Investors in Space (Series A), Investors in Medical Devices (Series A), Investors in Manufacturing (Series A), Investors in EnergyTech (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in Space (Series A), Investors in EnergyTech (Series A), Investors in BioTech (Series A), Investors in Manufacturing (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in DeepTech (Series A), Investors in DeepTech (Series A), Investors in BioTech (Series A), Investors in Space (Series A), Investors in EnergyTech (Series A), Investors in Manufacturing (Series A), Investors in Enterprise (Series A), Investors in Material Science (Series A), Investors in AI (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in AI (Series A), Investors in EnergyTech (Series A), Investors in Enterprise (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in BioTech (Series A), Investors in Medical Devices (Series A), Investors in Manufacturing (Series A), Investors in Material Science (Series A), Investors in Space (Series A), Investors in DeepTech (Series A), Investors in AI (Series A), Investors in AI (Series A), Investors in EnergyTech (Series A), Investors in Enterprise (Series A), Investors in BioTech (Series A), Investors in Medical Devices (Series A), Investors in Enterprise (Series A), Investors in Manufacturing (Series A), Investors in Space (Series A), Investors in DeepTech (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in EnergyTech (Series A), Investors in BioTech (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in AI (Series A), Investors in BioTech (Series A), Investors in Enterprise (Series A), Investors in AI (Series A), Investors in Enterprise (Series A), Investors in Raleigh-Durham / Southeast US (Other Lists), Investors in Female Investors (Other Lists), Investors in Midwest (Other Lists), Investors in Los Angeles / Southern California (Other Lists), Investors in Boston / New England (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in San Francisco Bay Area (Other Lists)
Photo of Inga Deakin, Principal at Molten Ventures
Inga Deakin
Molten Ventures·Principal
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Raleigh (NC), Investors in London
Investors in Medical Devices (Seed), Investors in Medical Devices (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in Health IT (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Seed), Investors in Medical Devices (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in Medical Devices (Series A), Investors in Medical Devices (Series A), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series A), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Medical Devices (Series A), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series B), Investors in Medical Devices (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Raleigh-Durham / Southeast US (Other Lists), Investors in London (Other Lists)
Photo of Mike Dial, Partner at Hatteras Venture Partners
Mike Dial
Sweet spot: $2.0M
Range: $400K - $4.0M
Investors in Durham (NC), Investors in Raleigh-Durham / Southeast US
Photo of Jon Kaiden, Managing Partner at Baleon Capital
Jon Kaiden
Baleon Capital·Managing Partner
Sweet spot: $7.5M
Range: $5.0M - $10.0M
Investors in Boca Raton (FL)
Photo of Clay Thorp, General Partner at Hatteras Venture Partners
Clay Thorp
Hatteras Venture Partners·General Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Chapel Hill (NC)
Investors in Diagnostics (Seed), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Diagnostics (Seed), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Diagnostics (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Diagnostics (Series A), Investors in Pharmaceuticals (Series A), Investors in Medical Devices (Series A), Investors in BioTech (Series A), Investors in Raleigh-Durham / Southeast US (Other Lists)
Photo of Christy Luquire, Managing Director at Texas Halo Fund
Christy Luquire
Texas Halo Fund·Managing Director
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Charlotte (NC)
Investors in Diagnostics (Seed), Investors in Medical Devices (Seed), Investors in AgTech (Seed), Investors in Diagnostics (Seed), Investors in Medical Devices (Seed), Investors in AgTech (Seed), Investors in Diagnostics (Series A), Investors in Medical Devices (Series A), Investors in AgTech (Series A), Investors in Diagnostics (Series A), Investors in Medical Devices (Series A), Investors in AgTech (Series A), Investors in Raleigh-Durham / Southeast US (Other Lists)
Photo of Stephen Liu, General Partner at BioVentures Investors
Stephen Liu
BioVentures Investors·General Partner
Sweet spot: $10.0M
Range: $5.0M - $25.0M
Investors in Bradenton (FL)
Photo of Tom Masterson, Managing Director at Allele Capital Partners
Tom Masterson
Allele Capital Partners·Managing Director
Sweet spot: $1.5M
Range: $100K - $5.0M